1 |
CHARLIER E, DEROYER C, CIREGIA F, et al.. Chondrocyte dedifferentiation and osteoarthritis (OA) [J]. Biochem. Pharmacol., 2019, 165:49-65.
|
2 |
NEES T A, ROSSHIRT N, REINER T, et al.. Inflammation and osteoarthritis-related pain [J]. Schmerz, 2019,33(1):4-12.
|
3 |
MATHIESSEN A, CONAGHAN P G, Synovitis in osteoarthritis: current understanding with therapeutic implications [J/OL]. Arthritis. Res. Ther., 2017, 19:18[2017-02-02]..
|
4 |
ROEMER F W, KASSIM J M, GUERMAZI A, et al.. Anatomical distribution of synovitis in knee osteoarthritis and its association with joint effusion assessed on non-enhanced and contrast-enhanced MRI [J]. Osteoarth. Cartilage, 2010, 18(10): 1269-1274.
|
5 |
HUGLE T, GEURTS J. What drives osteoarthritis-synovial versus subchondral bone pathology [J]. Rheumatology (Oxford), 2017, 56(9): 1461-1471.
|
6 |
MOBASHERI A, BAY-JENSEN A C, SPIL W E, et al.. Osteoarthritis year in review 2016: biomarkers (biochemical markers) [J]. Osteoarth. Cartilage., 2017, 25(2): 199-208.
|
7 |
LI J, DING Y, LI A. Identification of COL 1A1 and COL1A2 as candidate prognostic factors in gastric cancer[J/OL]. World J. Surg. Oncol., 2016, 14(1): 297[2010-11-29]. .
|
8 |
KUIVANIEMI H, TROMP G. Type Ⅲ collagen (COL3A1): Gene and protein structure, tissue distribution, and associated diseases[J]. Gene, 2019, 707: 151-171.
|
9 |
SIEBUHR A S, PETERSEN K, ARENDT-NIELSEN K, et al.. Identification and characterisation of osteoarthritis patients with inflammation derived tissue turnover [J]. Osteoarth. Cartil., 2014, 22(1): 44-50.
|
10 |
KJELGAARD-PETERSEN C, SIEBUHR A, CHRISTIANSENH T, et al.. Synovitis biomarkers: ex vivo characterization of three biomarkers for identification of inflammatory osteoarthritis[J]. Biomarkers., 2015, 20(8): 547-556.
|
11 |
SKJOT-ARKIL H, SCHETT G, ZHANG Y, et al.. Investigation of two novel biochemical markers of inflammation, matrix metalloproteinase and cathepsin generated fragments of C-reactive protein, in patients with ankylosing spondylitis [J]. Clin. Exp. Rheumatol., 2012, 30(3): 371-379.
|
12 |
PETERSEN K, SIEBUHR A, GRAVEN-NIELSENl T, et al.. Sensitization and serological biomarkers in knee osteoarthritis patients with different degrees of synovitis [J]. Clin. J. Pain., 2016, 32(10): 841-848.
|
13 |
LITWINIUK M, KREJNER A, SPEYRER M, et al.. Hyaluronic acid in inflammation and tissue regeneration [J]. Wounds, 2016, 28(3): 78-88.
|
14 |
STERN R, JEDRZEJAS M. Hyaluronidases: their genomics, structures, and mechanisms of action [J]. Chem. Rev., 2006, 106(3): 818-839.
|
15 |
TURAN Y, BAL S, GURGAN A, et al.. Serum hyaluronan levels in patients with knee osteoarthritis [J]. Clin. Rheumatol., 2007, 26(8): 1293-1298.
|
16 |
SASAKI E, TSUDA E, YAMAMOTO Y, et al.. Serum hyaluronic acid concentration predicts the progression of joint space narrowing in normal knees and established knee osteoarthritis - a five-year prospective cohort study [J/OL]. Arthritis Res. Ther., 2015, 17: 283[2016-10-10]. .
|
17 |
MELINCOVICI C, BOSCA A, SUSMAN S, et al.. Vascular endothelial growth factor (VEGF)-key factor in normal and pathological angiogenesis [J]. Rom. J. Morphol. Embryol., 2018, 59(2): 455-467.
|
18 |
MAPP P I, WALSH D A. Mechanisms and targets of angiogenesis and nerve growth in osteoarthritis [J]. Nat. Rev. Rheumatol., 2012, 8(7): 390-398.
|
19 |
段鑫,李奇,林荔军,等.骨关节炎滑膜组织中缺氧诱导因子-1α、血管内皮生长因子的表达[J].南方医科大学学报,2011,31(1):117-120.
|
20 |
DEMG S, JIANLIN Z, PENG H, et al.. Local intraarticular injection of vascular endothelial growth factor accelerates articular cartilage degeneration in rat osteoarthritis model [J]. Mol. Med. Rep., 2018, 17(5): 6311-6318.
|
21 |
OZLER K, AKTAS E, ATAY C, et al.. Serum and knee synovial fluid matrix metalloproteinase-13 and tumor necrosis factor-alpha levels in patients with late-stage osteoarthritis [J]. Acta Orthop. Traumatol. Turc., 2016, 50(3): 356-361.
|
22 |
ATTUR M, STATNIKOV A, SAMUELS J, et al.. Plasma levels of interleukin-1 receptor antagonist (IL1Ra) predict radiographic progression of symptomatic knee osteoarthritis [J]. Osteoarthritis Cartilage, 2015, 23(11): 1915-1924.
|
23 |
YANG F, ZHOU S, WANG S, et al.. Epigenetic modifications of interleukin-6 in synovial fibroblasts from osteoarthritis patients [J/OL]. Sci. Rep., 2017, 7: 43592[2017-03-06]. .
|
24 |
BAGGIOLINI M, CLARK-LEWIS I. Interleukin-8, a chemotactic and inflammatory cytokine [J]. FEBS Lett., 1992, 307(1): 97-101.
|
25 |
GUANGFENG R, JIANHUA X, KNAG W, et al.. Associations between serum IL-8 and knee symptoms, joint structures, and cartilage or bone biomarkers in patients with knee osteoarthritis [J]. Clin. Rheumatol., 2019, 38(12): 3609-3617.
|
26 |
KOH S M, CHAN C K, TEO S H, et al.. Elevated plasma and synovial fluid interleukin-8 and interleukin-18 may be associated with the pathogenesis of knee osteoarthritis [J]. Knee, 2020, 27(1): 26-35.
|
27 |
MABEY T, HONSAWEK S, TANAVALEE A, et al.. Plasma and synovial fluid inflammatory cytokine profiles in primary knee osteoarthritis [J]. Biomarkers, 2016, 21(7): 639-644.
|
28 |
MANTELL LL, PARRISH WR, ULLOA L, et al.. Hmgb-1 as a therapeutic target for infectious and inflammatory disorders [J]. Shock, 2006, 25(1): 4-11.
|
29 |
HOU C H, FONG Y C, TANG C H. HMGB-1 induces IL-6 production in human synovial fibroblasts through c-Src, Akt and NF-kappaB pathways [J]. J. Cell Physiol., 2011, 226(8): 2006-2015.
|
30 |
KOKKOLA R, SUNDBERG E, ULFGRENl A K, et al.. High mobility group box chromosomal protein 1: a novel proinflammatory mediator in synovitis[J]. Arthr. Rheum., 2002, 46(10): 2598-2603.
|
31 |
KE X, JIN G, YANG Y, et al.. Synovial fluid HMGB-1 levels are associated with osteoarthritis severity [J]. Clin. Lab., 2015, 61(7): 809-818.
|
32 |
YINGJIAN Y, GUIYANG L, DONG C, et al.. YKL-40 as a novel biomarker in cardio-metabolic disorders and inflammatory diseases [J]. Clin. Chim. Acta, 2020, 511: 40-46.
|
33 |
VOLCK B, JOHANSEN J S, STOLTENBERG M, et al.. Studies on YKL-40 in knee joints of patients with rheumatoid arthritis and osteoarthritis. Involvement of YKL-40 in the joint pathology [J]. Osteoarth. Cartilage, 2001, 9(3): 203-214.
|
34 |
JOHANSEN J S, HVOLRIS J, HANSEN M, et al.. Serum YKL-40 levels in healthy children and adults. Comparison with serum and synovial fluid levels of YKL-40 in patients with osteoarthritis or trauma of the knee joint [J]. Br. J. Rheumatol., 1996, 35(6): 553-559.
|